Skip to content
Home/Companies/Pharma/Crossject
CR

Crossject

Pharma·France·Active·1yr hold

Crossject is a healthcare company, headquartered in France.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Crossject?

Crossject is currently owned by VATEL CAPITAL through Vatel Flexible (2021 vintage), since 2025. Across its history, Crossject has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

VATEL CAPITAL
Most recent investor
VATEL CAPITAL
Vatel Flexible · 2021 · Evergreen
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by VATEL CAPITAL and A Plus Finance since 2025.
Co-invest · 2 holders · 2025 · present
VATEL CAPITAL
VATEL CAPITALActive
2025 · present · Vatel Flexible · 2021 · Evergreen
MOIC
–
A Plus Finance
A Plus FinanceActive
2025 · present · A Plus Finance Portfolio · Buyout
MOIC
–

More from Vatel Flexible

Other portfolio companies in the same fund.

ENOGIA
Active
EnergyFrance· 2025
Entech
Active
EnergyFrance· 2025
Haffner Energy
Active
EnergyFrance· 2025
Hoffmann Green Cement
Active
ClimateTechFrance· 2025
IZNES
Active
FintechFrance· 2025
Largo
Active
E-commerceFrance· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings